Intech Investment Management Reduces $10M in Colgate-Palmolive Company ($CL)

Intech Investment Management recently filed a 13F with the SEC, revealing a significant reduction in its holdings of Colgate-Palmolive Company (NYSE: CL). The firm cut its stake by 113,364 shares, a 28.9% decrease, leaving it with 278,568 shares valued at approximately $24.9 million as of the filing date.

What Changed in Intech Investment Management's Colgate-Palmolive Position

Intech Investment Management decided to reduce its investment in Colgate-Palmolive, moving from 391,932 shares to 278,568 shares. This reduction of 113,364 shares represents a 28.9% decrease in their position. The remaining shares are valued at about $24.9 million.

Other Institutional Activity in Colgate-Palmolive

Other major funds have also adjusted their positions in Colgate-Palmolive. BlackRock, Inc. increased its holdings by 2,171,094 shares, bringing its total to 72,643,002 shares valued at around $6.19 billion. Price T Rowe Associates Inc /MD/ added 2,541,888 shares, ending with 33,729,165 shares worth $2.87 billion. Meanwhile, State Street Corp reduced its stake by 755,303 shares, holding 47,719,482 shares valued at approximately $4.07 billion. Geode Capital Management, LLC grew its position by 796,389 shares, totaling 22,900,290 shares worth $1.97 billion.

Colgate-Palmolive Stock Snapshot

Shares of Colgate-Palmolive (NYSE: CL) are trading around $89.45. The company has a market capitalization of approximately $71.6 billion. It holds a P/E ratio of 34.7 and a forward P/E of 22.1, with a beta of 0.322, indicating lower volatility compared to the market. The stock's 52-week range is between $74.55 and $99.33, with a 50-day moving average of $86.78 and a 200-day moving average of $84.28.

Recent Earnings

Colgate-Palmolive reported revenue of $20.8 billion, reflecting a growth rate of 8.4%. The net margin stands at 10%, while the return on equity is 3.6%. The company is scheduled to announce its next earnings on July 31, 2026.

Dividend

Colgate-Palmolive offers an annual dividend rate of $2.12, yielding 2.37% based on its current stock price. The dividend payout ratio is 80.6%.

Insider Buying and Selling at Colgate-Palmolive Company

Recent insider transactions at Colgate-Palmolive include EVP and Controller Malcolm Gregory selling 2,300 shares at an average price of $88.44 on May 15, 2026. On May 11, 2026, several insiders, including Lisa Edwards, Kimberly Nelson, Brian Newman, and John Cahill, purchased shares, though the transaction prices were not disclosed.

Analysts Set New Price Targets

Several analysts have updated their ratings and price targets for Colgate-Palmolive. On June 12, 2026, Bernstein initiated coverage with a 'hold' rating and a $96 target. Barclays maintained its 'hold' rating with an $80 target on May 5, 2026. JP Morgan and UBS both reiterated their 'buy' ratings with targets of $96 and $100, respectively, on May 4, 2026. The consensus recommendation for Colgate-Palmolive is 'buy', with an average target price of $95.85 based on 20 analyst opinions.

About Colgate-Palmolive

Colgate-Palmolive Company, based in New York, is a leading consumer goods firm operating in the Consumer Defensive sector. It manufactures and sells a range of household and personal products, including oral care items, soaps, and pet nutrition products. With a history dating back to 1806, the company markets its products under well-known brands such as Colgate, Palmolive, and Hill's Science Diet. Led by CEO Noel R. Wallace, Colgate-Palmolive employs about 33,600 people worldwide.

Bottom Line

Intech Investment Management's recent 13F filing shows a significant reduction in its stake in Colgate-Palmolive, reflecting changes in its investment strategy. Investors will keep a close eye on Colgate-Palmolive's performance, particularly with its upcoming earnings report on July 31, 2026. The company's strong market position and analyst support continue to make it a focal point for institutional and individual investors alike.